G. Michael Landis

Insider Reports History

Location
Philadelphia, PA
Signature
/s/ G. Michael Landis
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by G. Michael Landis:

Company Role Class Num Shares Value Price $ Report Date Ownership
Polaryx Therapeutics, Inc. Chief Financial Officer, Director Common Stock 228,225 18 Feb 2026 Direct

Insider Reports Filed by G. Michael Landis

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PLYX Polaryx Therapeutics, Inc. 18 Feb 2026 1 +$7,991 4 Chief Financial Officer, Director 20 Feb 2026, 16:41
PLYX Polaryx Therapeutics, Inc. 29 Jan 2026 0 $0 3 Chief Financial Officer, Director 29 Jan 2026, 16:43